Skip to main content
Expertise in Alzheimer's Disease

What is early-onset Alzheimer's disease?

Early-onset Alzheimer’s is a rare form of the disease that affects individuals younger than 65 years of age at the time of diagnosis. Approximately 250,000 of the 5.7 million people in the United States diagnosed with Alzheimer’s experience early-onset.

Early-onset Alzheimer’s is often referred to as “younger Alzheimer’s” to avoid confusion with early-stage Alzheimer’s disease.

Disease Characteristics

Individuals with early-onset Alzheimer’s demonstrate more often atypical presentations than those with late-onset Alzheimer’s disease. Many of those with early-onset don’t have significant memory loss initially – the classic hallmark symptom of Alzheimer’s. Their disease progression does not begin with symptoms of forgetfulness. Some of these individuals present with visual symptoms – inability to see the full picture giving them in essence a “tunnel vision”, impaired depth perception or inability to recognize faces – or impaired speech/difficulty coming up with words in conversation.

These unusual symptoms present one of the biggest challenges in the diagnostic process. Since the presentation of early-onset is confusing, individuals with the beginning stages of the disease are often misdiagnosed and labeled as having a psychiatric disease, ultimately resulting in them not receiving the care and education they need. Early-onset Alzheimer’s disease also progresses much faster than late-onset.

Alzheimer's Research

IU School of Medicine investigators are studying the characteristics of early-onset Alzheimer’s with hopes of finding a cure.

EARLY-ONSET ALZHEIMER'S

Forms

Various forms of early-onset Alzheimer’s disease exist and they have specific characteristics.

  • Amnestic Variant

    Memory predominant cases present themselves much like late-onset Alzheimer’s disease. Some have visual variances associated with the disease such as not being able to integrate everything within one visual field (i.e. tunnel vision). These individuals cannot fully appreciate the remaining stimuli in the entire environment.

  • Logopenic Aphasia Variant
    Language deficit individuals have difficulty finding the “right words” to express themselves, resulting in distressed speech. As the language deficit progresses, the individual becomes less able to communicate with others.
  • Dysexecutive Variant
    Loss in judgement and problem solving/executive skills results in irrational actions, impulsive behaviors and what researchers and physicians observe in frontotemporal dementia.
  • Visual Variant
    This variant relates to posterior cortical atrophy, which triggers difficulty with visual tasks such as reading a line of text, inability to perceive more than one object at a time, impaired depth perception, judging distances or inability to recognize faces, etc.

Common Questions

  • How early does early-onset Alzheimer's disease begin to appear?
    Early-onset Alzheimer’s typically appears in the 40s, 50s and early 60s. However, it is not unheard of for an individual to be diagnosed in their 20s or 30s, especially in families who carry one of the three genetic mutations predicting early-onset Alzheimer’s disease.
  • Is there a certain ethnic group that is more susceptible to developing early-onset Alzheimer's than others?
    Since very few single-site research studies have been conducted on early-onset Alzheimer’s disease, the data that is available only reflects the local demographic of the individual study location.
  • What is the life expectancy for someone who is diagnosed with early-onset Alzheimer's?
    The life expectancy for an individual diagnosed with early-onset Alzheimer’s is unknown due to the rarity of this form of Alzheimer’s and the fact that very few research studies have been done to date. The average life expectancy for an individual diagnosed with late-onset Alzheimer’s is between 8-12 years. It is believed that early onset Alzheimer’s has a more aggressive disease course and progresses faster.
  • What known factors may play into the development of earlyonset Alzheimer's disease; i.e., alcohol, obesity, diabetes, etc.?
    This is another unknown answer for now; however, researchers at IU School of Medicine would not expect any of the above factors to be the case for development. Since early-onset cases develop in younger individuals, these patients rarely have high blood pressure, cholesterol or other chronic diseases which may have an impact on the body and brain. It is more likely that genetic factors have a more significant role in someone developing the disease before 65.
  • How can one be tested for early-onset Alzheimer's?
    The diagnosis of early-onset Alzheimer’s remains a clinical one. In the cases with known genetic mutations, pre-symptomatic identification of individuals at risk is possible. Children of individuals who carry the mutation are able to receive genetic testing when they reach 18 years of age.
  • Are there ways to avoid or help offset early-onset Alzheimer's and other forms of dementia?
    Like any other brain disease, the healthier the brain is, the more damage it can withstand without any demonstrated symptoms. Leading a healthy lifestyle with mental and cognitive stimulation, physical exercise and a healthy diet such as the Mediterranean diet helps to protect the brain, therefore allowing the individual to live a healthier life.
  • What are the greatest challenges of medical research in early-onset Alzheimer's disease?
    Recruitment for studies is by far the greatest challenge for medical research as it relates to early-onset Alzheimer’s since it’s such a rare disease. Raising awareness among primary care physicians, neurologists, psychiatrists and other health care providers significantly increases the likelihood for detection of early-onset cases, allowing the provider to refer the patient to participate in a research study such as LEADS. In addition, finding individuals to serve as control cases for the study proves difficult as it is a large time commitment that is strictly voluntary.
Dr. Apostolova sitting with a patient and smiling

LEADS

Led by Liana Apostolova, MD, the Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS) explores early-onset Alzheimer's disease that is not genetic.
Learn More LEADS

Faculty

Faculty investigators studying Alzheimer’s disease receive generous grant awards and international support to advance their studies
Learn More Faculty